Blink Health Inc., a Delaware corporatio – Trademark Portfolio

Entity Type: 11

Blink Health Inc., a Delaware corporatio holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. The owner is based in New York, NY.

1407 Broadway, Suite 2100

New York, NY 10018

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Blink Health Inc., a Delaware corporatio's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Blink Health Inc., a Delaware corporatio have?

Blink Health Inc., a Delaware corporatio has 2 U.S. trademarks filed with the USPTO.

What trademark classes does Blink Health Inc., a Delaware corporatio file in?

Blink Health Inc., a Delaware corporatio files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Blink Health Inc., a Delaware corporatio's trademark registration success rate?

Blink Health Inc., a Delaware corporatio has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.